Library
PubMed
research article
Professional

Predicting Metabolic Syndrome Using Supervised Machine Learning: A Multivariate Parameter Approach.

Source: PubMed, NCBI / U.S. National Library of Medicine

International journal of molecular sciencesValdez Vega Rodolfo Iván, Noboa-Velástegui Jacqueline Alejandra, Fletes-Rayas Ana Lilia, et al.Published 10/11/2025Last synced 8/15/2026Status: syncedPMID: 41155195DOI: 10.3390/ijms26209897

Metabolic syndrome (MetS) is a complex condition characterized by a group of interconnected metabolic abnormalities. Due to its increasing prevalence, better predictive markers are needed. Therefore, this study aims to develop predictive models for MetS by integrating adipokines, metabolic and cardiovascular risk factors, and anthropometric indices. Data were collected from 381 subjects aged 20 to 59 years (242 women and 139 men) from Guadalajara, Jalisco, Mexico, who were classified as having MetS or non-MetS based on the ATP-III criteria. Four supervised machine learning models were developed-Logistic Regression (LR), Support Vector Machine (SVM), Random Forest (RF), and eXtreme Gradient Boosting (XGBoost)-and their performance was evaluated using the Area under the Curve (AUC), calibration curves, Decision Curve Analysis (DCA), and local interpretability analysis. The RF and XGBoost models achieved the highest AUCs (0.940 and 0.954). The RF and LR models were the best calibrated and showed the highest net benefit in DCA. Key variables included age, anthropometric indices (BRI and DAI), insulin resistance measures (HOMA-IR), lipid profiles (sdLDL-C and LDL-C), and high-molecular-weight adiponectin, used to classify the presence of MetS. The results highlight the usefulness of specific models and the importance of anthropometric variables, cardiovascular risk factors, metabolic profiles, and adiponectin as indicators of MetS.

Educational only
This information is for general education and is not medical advice. Always talk to a licensed U.S. clinician about your situation, medications, or treatment decisions.